Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Colorectal Cancer ◽

Human Colorectal Cancer Cell ◽

Colorectal Cancer Cell Lines ◽

Epidermal Growth ◽

Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer

Clinical Pharmacokinetics ◽

10.1007/s40262-017-0590-9 ◽

2017 ◽

Vol 57 (4) ◽

pp. 455-473 ◽

Cited By ~ 4

Author(s):

Sander Ketzer ◽

Kirsten Schimmel ◽

Miriam Koopman ◽

Henk-Jan Guchelaar

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Pharmacokinetics And Pharmacodynamics ◽

Clinical Pharmacokinetics ◽

Epidermal Growth ◽

Imaging Epidermal Growth Factor Receptor Phosphorylation in Human Colorectal Cancer Cells and Human Tissues

Journal of Biological Chemistry ◽

10.1074/jbc.m504485200 ◽

2005 ◽

Vol 280 (30) ◽

pp. 27826-27831 ◽

Cited By ~ 22

Author(s):

Michael Keese ◽

Richard J. Magdeburg ◽

Torsten Herzog ◽

Till Hasenberg ◽

Martin Offterdinger ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Tissues ◽

Human Colorectal Cancer ◽

Colorectal Cancer Cells ◽

Epidermal Growth ◽

Human Colorectal Cancer Cells

PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-2961 ◽

2009 ◽

Vol 15 (9) ◽

pp. 3184-3188 ◽

Cited By ~ 217

Author(s):

Hans Prenen ◽

Jef De Schutter ◽

Bart Jacobs ◽

Wendy De Roock ◽

Bart Biesmans ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Major Determinant ◽

Pik3ca Mutations ◽

Epidermal Growth ◽

Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer

Oncogene ◽

10.1038/sj.onc.1210381 ◽

2007 ◽

Vol 26 (25) ◽

pp. 3654-3660 ◽

Cited By ~ 99

Author(s):

G Galizia ◽

E Lieto ◽

F De Vita ◽

M Orditura ◽

P Castellano ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Colorectal Cancer ◽

Epidermal Growth ◽

Receptor Monoclonal Antibody

Economic impact in the management of dermatologic toxicities (dTs) induced by the epidermal growth factor receptor inhibitor (EGFRI) cetuximab in colorectal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.3569 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 3569-3569 ◽

Cited By ~ 1

Author(s):

J. H. Borovicka ◽

M. F. Mulcahy ◽

C. Calahan ◽

D. P. West ◽

M. E. Lacouture

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Economic Impact ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings

Cancer Epidemiology Biomarkers & Prevention ◽

10.1158/1055-9965.epi-12-0545 ◽

2012 ◽

Vol 22 (1) ◽

pp. 91-101 ◽

Cited By ~ 20

Author(s):

Jennifer Webster ◽

Tia L. Kauffman ◽

Heather Spencer Feigelson ◽

Pamala A. Pawloski ◽

Adedayo A. Onitilo ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Community Settings ◽

Epidermal Growth ◽

Inhibitor Treatment ◽

ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

British Journal of Cancer ◽

10.1038/sj.bjc.6600182 ◽

2002 ◽

Vol 86 (7) ◽

pp. 1157-1161 ◽

Cited By ~ 133

Author(s):

K J Williams ◽

B A Telfer ◽

I J Stratford ◽

S R Wedge

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Xenograft Model ◽

Growth Factor Receptor ◽

Human Colorectal Cancer ◽

Epidermal Growth

Effective therapy of epidermal growth factor receptor inhibitor-associated dermatologic side effects in a patient with metastatic colorectal cancer: a and review of literature

Advances in Dermatology and Allergology ◽

10.5114/pdia.2012.30475 ◽

2012 ◽

Vol 4 ◽

pp. 324-329

Author(s):

Alicja Góralczyk ◽

Małgorzata Sokołowska-Wojdyło ◽

Anna Kowalczyk ◽

Aneta Szczerkowska-Dobosz ◽

Wioletta Barańska-Rybak

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Side Effects ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Review Of Literature ◽

Epidermal Growth ◽

Abstract 2644: Histone deacetylase 6 plays a critical role in sulfiredoxin-mediated activation of the epidermal growth factor receptor signaling in human colorectal cancer

10.1158/1538-7445.am2019-2644 ◽

2019 ◽

Author(s):

Qi Ying ◽

Hong Jiang ◽

B. Mark Evers ◽

Qiou Wei

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Critical Role ◽

Growth Factor Receptor ◽

Histone Deacetylase 6 ◽

Human Colorectal Cancer ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer

BMJ Case Reports ◽

10.1136/bcr-2018-228968 ◽

2019 ◽

Vol 12 (4) ◽

pp. e228968 ◽

Cited By ~ 2

Author(s):

Leonor Vasconcelos Matos ◽

Ana Pissarra ◽

Mariana Malheiro ◽

Ana Neto Plácido

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽